Company research
Xencor Inc
CIK 1326732Updated Nov 13, 2026
SecurityXNCR · NASDAQ · equity
XNCR price & chart
Loading TradingView…
NASDAQ:XNCR on TradingView ↗In the news
Recent filings
4 filing
144 filing
SCHEDULE 13G/A - filed by PRIMECAP MANAGEMENT CO/CA/ regarding Xencor Inc
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Show 5 more recent filings
Results of Operations and Financial Condition · Regulation FD Disclosure · Other Events
Items 2.02, 7.01, 8.01, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
SCHEDULE 13G - filed by VANGUARD CAPITAL MANAGEMENT LLC regarding Xencor Inc
Entry into a Material Definitive Agreement · Results of Operations and Financial Condition · Regulation FD Disclosure
Items 1.01, 2.02, 7.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 868,811,000Source | 999,904,000Source | 724,960,000Source | 879,424,000Source | 840,619,000Source | 736,846,000Source | 904,689,000Source | 896,850,000Source | 875,495,000Source | 951,945,000Source | 965,135,000Source | 846,266,000Source |
| Property, Plant and Equipment, NetUSD | 54,587,000Source | 62,400,000Source | 50,013,000Source | 56,791,000Source | 63,868,000Source | 51,492,000Source | 58,808,000Source | 63,540,000Source | 53,308,000Source | 59,800,000Source | 66,124,000Source | 59,183,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 9,468,000Source | 17,919,000Source | 6,524,000Source | 11,252,000Source | 18,778,000Source | 7,602,000Source | 13,363,000Source | 18,852,000Source | 8,385,000Source | 18,485,000Source | 18,663,000Source | 18,500,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 28,291,000Source | 29,031,000Source | 44,663,000Source | 44,442,000Source | 30,768,000Source | 14,170,000Source | 39,675,000Source | 31,034,000Source | 54,073,000Source | 40,875,000Source | 53,790,000Source | 53,942,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 21,805,000Source | 25,872,000Source | 42,234,000Source | 47,554,000Source | 35,923,000Source | 12,001,000Source | 37,785,000Source | 22,181,000Source | 29,299,000Source | 60,849,000Source | 23,739,000Source | 28,997,000Source |
| Assets, CurrentUSD | 518,441,000Source | 589,597,000Source | 523,213,000Source | 513,150,000Source | 568,922,000Source | 482,855,000Source | 521,271,000Source | 574,847,000Source | 599,821,000Source | 577,601,000Source | 635,603,000Source | 675,342,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 25,592,000Source | 20,748,000Source | 24,527,000Source | 21,732,000Source | 24,588,000Source | 25,904,000Source | 13,920,000Source | 16,730,000Source | 22,789,000Source | 18,977,000Source | 18,139,000Source | 23,283,000Source |
| Operating Lease, Right-of-Use AssetUSD | 38,371,000Source | 38,831,000Source | 35,986,000Source | 37,048,000Source | 39,527,000Source | 36,815,000Source | 37,650,000Source | 40,211,000Source | 37,592,000Source | 38,341,000Source | 33,995,000Source | 34,419,000Source |
| Other Assets, NoncurrentUSD | 498,000Source | 498,000Source | 498,000Source | 498,000Source | 498,000Source | 498,000Source | 498,000Source | 498,000Source | 498,000Source | 498,000Source | 648,000Source | 613,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 243,495,000Source | 293,978,000Source | 221,732,000Source | 259,073,000Source | 291,905,000Source | 221,213,000Source | 264,815,000Source | 297,116,000Source | 239,908,000Source | 277,919,000Source | 303,048,000Source | 118,770,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | — | 0Source | — | — | 0Source | — | — | 0Source | — | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 714,000Source | 701,000Source | 744,000Source | 714,000Source | 619,000Source | 741,000Source | 712,000Source | 617,000Source | 718,000Source | 703,000Source | 611,000Source | 601,000Source |
| Additional Paid in CapitalUSD | 1,412,750,000Source | 1,364,846,000Source | 1,449,960,000Source | 1,402,658,000Source | 1,162,726,000Source | 1,439,740,000Source | 1,391,261,000Source | 1,144,468,000Source | 1,429,252,000Source | 1,381,607,000Source | 1,131,266,000Source | 1,072,132,000Source |
| Retained Earnings (Accumulated Deficit)USD | -789,306,000Source | -658,483,000Source | -946,604,000Source | -783,279,000Source | -612,195,000Source | -924,875,000Source | -752,454,000Source | -544,858,000Source | -795,959,000Source | -704,036,000Source | -471,418,000Source | -338,285,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 1,158,000Source | 1,800,000Source | -872,000Source | 258,000Source | -652,000Source | 27,000Source | 355,000Source | -154,000Source | 1,576,000Source | -663,000Source | 1,291,000Source | -6,952,000Source |
| Stockholders' Equity Attributable to ParentUSD | 625,316,000Source | 708,864,000Source | 503,228,000Source | 620,351,000Source | 550,498,000Source | 515,633,000Source | 639,874,000Source | 600,073,000Source | 635,587,000Source | 677,611,000Source | 661,750,000Source | 727,496,000Source |
| Liabilities and EquityUSD | 868,811,000Source | 999,904,000Source | 724,960,000Source | 879,424,000Source | 840,619,000Source | 736,846,000Source | 904,689,000Source | 896,850,000Source | 875,495,000Source | 951,945,000Source | 965,135,000Source | 846,266,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 86,485,000Source | 90,813,000Source | 81,865,000Source | 96,083,000Source | 75,587,000Source | 73,457,000Source | 88,436,000Source | 71,075,000Source | 95,907,000Source | 87,432,000Source | 73,915,000Source | 63,844,000Source |
| Operating Lease, Liability, CurrentUSD | 3,936,000Source | 2,181,000Source | 3,917,000Source | 3,380,000Source | 1,262,000Source | 4,034,000Source | 3,640,000Source | 2,079,000Source | 3,263,000Source | 3,009,000Source | 3,435,000Source | 4,708,000Source |
| Accounts Payable, CurrentUSD | 9,079,000Source | 18,770,000Source | 12,648,000Source | 18,533,000Source | 15,838,000Source | 7,919,000Source | 16,191,000Source | 16,011,000Source | 10,828,000Source | 16,759,000Source | 13,914,000Source | 10,088,000Source |
| Operating Lease, Liability, NoncurrentUSD | 65,331,000Source | 66,489,000Source | 61,295,000Source | 64,551,000Source | 67,156,000Source | 62,596,000Source | 64,184,000Source | 66,810,000Source | 64,735,000Source | 65,338,000Source | 59,025,000Source | 54,926,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 0Source | -2,938,000Source | 0Source | 0Source | -1,784,000Source | 0Source | 0Source | -339,000Source | 0Source | -3,585,000Source | 337,000Source | — |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 28,108,000Source | 25,407,000Source | 36,446,000Source | 23,884,000Source | 19,557,000Source | 34,253,000Source | 16,063,000Source | 13,491,000Source | 34,960,000Source | 19,217,000Source | 23,564,000Source | 18,728,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 87,776,000Source | 128,340,000Source | 77,537,000Source | 94,736,000Source | 140,826,000Source | 82,124,000Source | 101,837,000Source | 150,895,000Source | 76,482,000Source | 115,159,000Source | 161,772,000Source | — |
| Other Liabilities, Noncurrent | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -6,027,000Source | -47,442,000Source | -21,729,000Source | -30,825,000Source | -128,916,000Source | -48,632,000Source | -92,137,000Source | -236,540,000Source | -133,296,000Source | -55,181,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 2,567,000Source | 2,693,000Source | 10,512,000Source | 12,107,000Source | 11,498,000Source | 8,799,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 10,092,000Source | 12,338,000Source | 9,192,000Source | 10,737,000Source | 9,561,000Source | 12,213,000Source | 43,227,000Source | 53,281,000Source | 53,755,000Source | 48,913,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -5,800,000Source | -23,405,000Source | -28,734,000Source | — | — | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -2,871,000Source | -568,000Source | -3,953,000Source | 2,845,000Source | 3,826,000Source | -3,913,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -67,628,000Source | -16,220,000Source | -135,117,000Source | -202,188,000Source | -77,926,000Source | 24,485,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 26,677,000Source | 13,668,000Source | 139,985,000Source | -7,872,000Source | -111,065,000Source | -119,725,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 610,000Source | 1,444,000Source | 3,150,000Source | 6,097,000Source | 18,448,000Source | 38,494,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 950,000Source | 1,249,000Source | 8,232,000Source | 197,152,000Source | 189,219,000Source | 5,702,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -40,001,000Source | -1,303,000Source | 13,100,000Source | -12,908,000Source | 228,000Source | -89,538,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 28,579,000Source | 29,416,000Source | 44,854,000Source | 44,728,000Source | 14,361,000Source | 39,959,000Source | 54,362,000Source | 41,262,000Source | 54,170,000Source | 53,942,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 1,000Source | 1,000Source | 5,000Source | 33,000Source | 22,000Source | 13,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | 3,014,000Source | 0Source | 7,312,000Source | 6,100,000Source | 0Source | 700,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | — | 53,300,000Source | 53,800,000Source | 48,900,000Source |
| Amortization of Intangible AssetsUSD | — | — | 200,000Source | 300,000Source | 200,000Source | 300,000Source | 200,000Source | 300,000Source | 900,000Source | 1,300,000Source | 1,300,000Source | 1,400,000Source |
| Equity Securities, FV-NI, Gain (Loss)USD | — | — | 44,201,000Source | 9,254,000Source | 18,064,000Source | 4,967,000Source | -51,929,000Source | 941,000Source | 101,514,000Source | -31,422,000Source | -395,000Source | 23,434,000Source |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | — | -10,000Source | 92,000Source | 0Source | -12,000Source | 0Source | 0Source | 14,388,000Source | 1,280,000Source | 0Source | 0Source |
| Equity Securities, FV-NI, Unrealized Gain (Loss)USD | — | — | 44,211,000Source | 9,162,000Source | 18,064,000Source | 4,979,000Source | -51,929,000Source | 941,000Source | 87,126,000Source | -32,702,000Source | -395,000Source | 23,434,000Source |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | 20,430,000Source | 0Source | 100,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | — | 0Source | 0Source | -1,577,000Source | -1,379,000Source | -145,000Source |
| General and Administrative ExpenseUSD | — | — | 14,151,000Source | 14,767,000Source | 16,384,000Source | 15,115,000Source | 17,709,000Source | 17,337,000Source | 63,644,000Source | 61,215,000Source | 53,379,000Source | 47,489,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | 1,600,000Source | 0Source | 800,000Source | 1,900,000Source | — | 4,900,000Source | 9,200,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | -190,000Source | -250,000Source | 280,000Source | 367,000Source | 2,504,000Source | 1,617,000Source | 13,662,000Source | 673,000Source |
| InterestExpenseNonoperatingUSD | — | — | 7,665,000Source | 9,026,000Source | 7,352,000Source | 8,243,000Source | 4,700,000Source | 8,665,000Source | 31,927,000Source | 36,643,000Source | — | — |
| Investment Income, InterestUSD | — | — | 6,538,000Source | 7,537,000Source | 4,800,000Source | 7,248,000Source | 5,459,000Source | 7,538,000Source | 27,524,000Source | — | 19,331,000Source | — |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | — | — | — | — | — | — | 37,000Source | — | 0Source |
| Marketable Securities, Unrealized Gain (Loss)USD | — | — | — | — | — | — | -51,929,000Source | 941,000Source | 87,126,000Source | -1,954,000Source | 8,243,000Source | -5,442,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -6,027,000Source | -46,288,000Source | -21,729,000Source | -30,825,000Source | -128,916,000Source | -48,418,000Source | -91,923,000Source | -232,618,000Source | -133,133,000Source | -55,181,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 0Source | -1,154,000Source | 0Source | 0Source | 0Source | -214,000Source | -214,000Source | -3,922,000Source | -163,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -6,027,000Source | -46,288,000Source | -21,729,000Source | -30,825,000Source | -128,916,000Source | -48,418,000Source | -91,923,000Source | -232,618,000Source | -133,133,000Source | -55,181,000Source |
| Nonoperating Income (Expense)USD | — | — | 41,492,000Source | 7,755,000Source | 15,149,000Source | 2,097,000Source | -50,774,000Source | -5,082,000Source | 87,869,000Source | -56,515,000Source | 12,728,000Source | 27,965,000Source |
| Operating ExpensesUSD | — | — | 68,518,000Source | 72,993,000Source | 88,289,000Source | 76,780,000Source | 82,378,000Source | 75,915,000Source | 303,078,000Source | 288,901,000Source | 306,977,000Source | 247,052,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -17,000Source | -10,000Source | 434,000Source | -17,000Source | 396,000Source | -31,000Source | -73,000Source | 50,000Source | -31,000Source | -286,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | 0Source | 201,256,000Source | 0Source | 0Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | — | — | — | — | — | — | — | — | 565,358,000Source | — | — |
| Proceeds from Noncontrolling InterestsUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 500,000Source | — |
| Operating Lease, Expense | — | — | —Source | — | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 20,999,000Source | 17,796,000Source | 51,221,000Source | 43,608,000Source | 4,516,000Source | 32,732,000Source | 125,576,000Source | 110,493,000Source | 174,615,000Source | 164,579,000Source |
| Operating Income (Loss)USD | — | — | -47,519,000Source | -55,197,000Source | -37,068,000Source | -33,172,000Source | -77,862,000Source | -43,183,000Source | -177,502,000Source | -178,408,000Source | -132,362,000Source | -82,473,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -17,000Source | -10,000Source | 434,000Source | -17,000Source | 396,000Source | -31,000Source | -73,000Source | 50,000Source | -31,000Source | -286,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -6,027,000Source | -47,442,000Source | -21,919,000Source | -31,075,000Source | -128,636,000Source | -48,265,000Source | -89,633,000Source | -234,923,000Source | -119,634,000Source | -54,508,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | -190,000Source | -250,000Source | 280,000Source | 367,000Source | 2,504,000Source | 1,617,000Source | 13,662,000Source | 673,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 0Source | -1,154,000Source | 0Source | 0Source | 0Source | -214,000Source | -214,000Source | -3,922,000Source | -163,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -6,027,000Source | -46,288,000Source | -21,729,000Source | -30,825,000Source | -128,916,000Source | -48,418,000Source | -91,923,000Source | -232,618,000Source | -133,133,000Source | -55,181,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.08Source | -0.72Source | -0.29Source | -0.41Source | -1.71Source | -0.66Source | -1.24Source | -3.58Source | -2.2Source | -0.93Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.08Source | -0.72Source | -0.29Source | -0.41Source | -1.71Source | -0.66Source | -1.24Source | -3.58Source | -2.2Source | -0.93Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 74,413,000Source | 64,023,000Source | 75,859,000Source | 74,279,000Source | 75,247,000Source | 73,667,000Source | 74,239,000Source | 65,041,265Source | 60,503,283Source | 59,652,461Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 74,413,000Source | 64,023,000Source | 75,859,000Source | 74,279,000Source | 75,247,000Source | 73,667,000Source | 74,239,000Source | 65,041,265Source | 60,503,283Source | 59,652,461Source |
| Interest Expense (non-operating)USD | — | — | 7,665,000Source | 9,026,000Source | 7,352,000Source | 8,243,000Source | 4,700,000Source | 8,665,000Source | 31,927,000Source | 36,643,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 200,000Source | 300,000Source | 200,000Source | 300,000Source | 200,000Source | 300,000Source | 900,000Source | 1,300,000Source | 1,300,000Source | 1,400,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 2,504,000Source | 1,617,000Source | 13,662,000Source | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 2,400,000Source | 2,800,000Source | 2,300,000Source | 2,400,000Source | 2,400,000Source | 2,400,000Source | 9,600,000Source | 10,800,000Source | 10,100,000Source | 7,400,000Source |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | — | -10,000Source | 92,000Source | 0Source | -12,000Source | 0Source | 0Source | 14,388,000Source | 1,280,000Source | 0Source | 0Source |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | 20,430,000Source | 0Source | 100,000Source |
| General and Administrative ExpenseUSD | — | — | 14,151,000Source | 14,767,000Source | 16,384,000Source | 15,115,000Source | 17,709,000Source | 17,337,000Source | 63,644,000Source | 61,215,000Source | 53,379,000Source | 47,489,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 6,177,000Source | — |
| Interest Income (Expense), NetUSD | — | — | — | — | — | — | — | — | — | 31,930,000Source | 18,626,000Source | 4,817,000Source |
| Investment Income, InterestUSD | — | — | 6,538,000Source | 7,537,000Source | 4,800,000Source | 7,248,000Source | 5,459,000Source | 7,538,000Source | 27,524,000Source | — | 19,331,000Source | — |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | — | — | — | — | — | — | — | — | — | 37,000Source | — | 0Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -6,027,000Source | -46,288,000Source | -21,729,000Source | -30,825,000Source | -128,916,000Source | -48,418,000Source | -91,923,000Source | -232,618,000Source | -133,133,000Source | -55,181,000Source |
| Nonoperating Income (Expense)USD | — | — | 41,492,000Source | 7,755,000Source | 15,149,000Source | 2,097,000Source | -50,774,000Source | -5,082,000Source | 87,869,000Source | -56,515,000Source | 12,728,000Source | 27,965,000Source |
| Operating ExpensesUSD | — | — | 68,518,000Source | 72,993,000Source | 88,289,000Source | 76,780,000Source | 82,378,000Source | 75,915,000Source | 303,078,000Source | 288,901,000Source | 306,977,000Source | 247,052,000Source |
| Research and Development ExpenseUSD | — | — | 54,367,000Source | 58,226,000Source | 71,905,000Source | 61,665,000Source | 64,669,000Source | 58,578,000Source | 239,434,000Source | 227,686,000Source | 253,598,000Source | 199,563,000Source |
| Operating Lease, Expense | — | — | —Source | — | — | — | — | — | — | — | — | — |
Offerings
Registration 333-293727
Filing attachments
ea030959601ex99-1.htm · 8-K · 2026-10-26
Exhibit 99.1 ® Designing Proteins Delivering Medicines Updated Results from Dose Expansion Cohorts in the Phase 1 Study of XmAb819 October 26, 2026 2 Today's Speakers Bassil Dahiyat, Ph. D. President & Chief Executive Officer Xencor Management Guest Speaker Sumanta Pal, M.D., F.A.S.C.O. Professor, Department of Medical Oncology & Therapeutics Research Vice Chair of Academic Affairs Co-director, Kidney Cancer Program City of Hope Comprehensive Cancer Center Dane Leone Executive Vice President &…
Read attachment ↗ea030959601ex99-2.htm · 8-K · 2026-10-26
Exhibit 99.2 Xencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and ENPP3+ Tumors -- 400 mcg/kg chosen as proposed IV RP3D based on 45.5% cORR, 55% uORR and 82% 6-month PFS Kaplan-Meier estimate -- -- Xencor plans to discuss a potential accelerated approval pathway with the FDA in key ccRCC patient subgroups in 1H2027 -- -- Xencor plans global rand…
Read attachment ↗xencor-sx3ex44formofindent.htm · S-3ASR · 2026-02-25
Exhibit 4.4 Xencor, Inc. INDENTURE Dated as of [ ] [ ] Trustee TABLE OF CONTENTS Page Article I. 1 DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.1 Definitions 1 Section 1.2 Other Definitions 3 Section 1.3 Incorporation by Reference of Trust Indenture Act 4 Section 1.4 Rules of Construction 4…
Read attachment ↗